Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1I've been diagnosed with a blood cancer like CLL or mantle cell lymphoma and my doctor is considering a BTK inhibitor — I've heard these drugs can affect blood pressure, so is this trial's home monitoring program something worth discussing as part of my treatment plan?
2. 2This trial isn't recruiting yet — do you know when it's expected to open, and would it make sense to start a BTK inhibitor now or wait to see if I could potentially participate once it opens?
3. 3The trial is focused on whether patients can consistently take their own blood pressure at home using a connected device at least 144 times over six months — is that kind of monitoring commitment realistic given everything else my treatment would involve?
4. 4Since this study is labeled 'Phase NA' and is really about monitoring adherence rather than testing a new drug, does joining it affect which BTK inhibitor I'd receive, or would I still get whatever treatment you'd recommend for my specific diagnosis?
5. 5Even if I don't end up in this trial, should I be routinely monitoring my blood pressure at home once I start a covalent BTK inhibitor, given that cardiovascular side effects are a known concern with these medications?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.